Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 12/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 12/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | FPR2 | P25090 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3343063 | 0.82 | TAS1R3 (0.46) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 | |
| SCHEMBL28051928 | 0.81 | TAS1R3 (0.58) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 | |
| SCHEMBL3343056 | 0.75 | ZDHHC20 (0.47) | PPARDTSHRFPR2ALDH1A1MAPK1 | |
| SCHEMBL10613517 | 0.75 | ZDHHC20 (0.51) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 | |
| SCHEMBL10877800 | 0.75 | TAS1R3 (0.51) | TAS1R3TAS1R1TSHRZDHHC20ZDHHC2 | |
| SCHEMBL8849822 | 0.75 | TAS1R3 (0.51) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 | |
| SCHEMBL6566575 | 0.74 | TAS1R3 (0.50) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 | |
| SCHEMBL2558578 | 0.74 | TAS1R3 (0.44) | TAS1R3TAS1R1TSHRZDHHC20ZDHHC2 | |
| SCHEMBL6510485 | 0.73 | TAS1R3 (0.50) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 | |
| SCHEMBL1592021 | 0.73 | TAS1R3 (0.46) | TAS1R3TAS1R1TSHRALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100160485-A1 | Hydrolysis stable self-etching, self-priming adhesive | KLEE JOACHIM | 2010-06-24 | — | — | US | disclosed |
| US-20080194730-A1 | Hydrolysis stable self-etching, self-priming adhesive | KLEE JOACHIM | 2008-08-14 | — | — | US | disclosed |
| EP-1437999-B1 | HYDROLYSIS STABLE SELF-ETCHING, SELF-PRIMING ADHESIVE | DENTSPLY DETREY GMBH (DE) | 2006-12-20 | — | — | EP | disclosed |
| US-20040266906-A1 | Hydrolysis stable self-etching,self-priming adhesive | KLEE JOACHIM (DE) | 2004-12-30 | — | — | US | disclosed |
| EP-1437999-A1 | HYDROLYSIS STABLE SELF-ETCHING, SELF-PRIMING ADHESIVE | DENTSPLY DETREY GmbH (DE) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003035013-A1 | HYDROLYSIS STABLE SELF-ETCHING, SELF-PRIMING ADHESIVE | DENTSPLY DETREY GMBH (DE) | 2003-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194730-A1 | Hydrolysis stable self-etching, self-priming adhesive | PPA1, PHOSPHO1, PDAP1 | TAS1R3 1414/4885TAS1R1 336/4885PPARD 3115/4885 |
| US-20100160485-A1 | Hydrolysis stable self-etching, self-priming adhesive | PPA1, PHOSPHO1, PDAP1 | TAS1R3 1414/4885TAS1R1 336/4885PPARD 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.